BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 24526735)

  • 1. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
    Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
    PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cells.
    Gakhar G; Bander NH; Nanus DM
    J Vis Exp; 2014 May; (87):. PubMed ID: 24894373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models.
    Haider MT; Freytag V; Krause L; Spethmann T; Gosau T; Beine MC; Knies C; Schröder-Schwarz J; Horn M; Riecken K; Lange T
    Clin Exp Metastasis; 2024 Apr; 41(2):103-115. PubMed ID: 38353934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo.
    Genduso S; Freytag V; Schetler D; Kirchner L; Schiecke A; Maar H; Wicklein D; Gebauer F; Bröker K; Stürken C; Milde-Langosch K; Oliveira-Ferrer L; Ricklefs FL; Ewald F; Wolters-Eisfeld G; Riecken K; Unrau L; Krause L; Bohnenberger H; Offermann A; Perner S; Sebens S; Lamszus K; Diehl L; Linder S; Jücker M; Schumacher U; Lange T
    J Hematol Oncol; 2023 Mar; 16(1):23. PubMed ID: 36932441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell E-selectin ligands determine partialefficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo.
    Lange T; Valentiner U; Wicklein D; Maar H; Labitzky V; Ahlers AK; Starzonek S; Genduso S; Staffeldt L; Pahlow C; Dück AM; Stürken C; Baranowsky A; Bauer AT; Bulk E; Schwab A; Riecken K; Börnchen C; Kiefmann R; Abraham V; DeLisser HM; Gemoll T; Habermann JK; Block A; Pantel K; Schumacher U
    Mol Ther; 2022 Apr; 30(4):1536-1552. PubMed ID: 35031433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.
    Spethmann T; Böckelmann LC; Labitzky V; Ahlers AK; Schröder-Schwarz J; Bonk S; Simon R; Sauter G; Huland H; Kypta R; Schumacher U; Lange T
    Mol Oncol; 2021 Jul; 15(7):1956-1969. PubMed ID: 33533127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of the human tumor cell binding to human vs. murine E- and P-selectin under static vs. dynamic conditions.
    Starzonek S; Maar H; Labitzky V; Wicklein D; Rossdam C; Buettner FFR; Wolters-Eisfeld G; Guengoer C; Wagener C; Schumacher U; Lange T
    Glycobiology; 2020 Aug; 30(9):695-709. PubMed ID: 32103235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice.
    Labitzky V; Baranowsky A; Maar H; Hanika S; Starzonek S; Ahlers AK; Stübke K; Koziolek EJ; Heine M; Schäfer P; Windhorst S; Jücker M; Riecken K; Amling M; Schinke T; Schumacher U; Valentiner U; Lange T
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32046143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma.
    Valentiner U; Knips J; Pries R; Clauditz T; Münscher A; Sauter G; Wollenberg B; Schumacher U
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31661833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.
    Namekawa T; Ikeda K; Horie-Inoue K; Inoue S
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer.
    Lange T; Oh-Hohenhorst SJ; Joosse SA; Pantel K; Hahn O; Gosau T; Dyshlovoy SA; Wellbrock J; Feldhaus S; Maar H; Gehrcke R; Kluth M; Simon R; Schlomm T; Huland H; Schumacher U
    Sci Rep; 2018 Dec; 8(1):17535. PubMed ID: 30510249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.
    Mueller N; Wicklein D; Eisenwort G; Jawhar M; Berger D; Stefanzl G; Greiner G; Boehm A; Kornauth C; Muellauer L; Sehner S; Hoermann G; Sperr WR; Staber PB; Jaeger U; Zuber J; Arock M; Schumacher U; Reiter A; Valent P
    Blood; 2018 Nov; 132(18):1936-1950. PubMed ID: 30018080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model.
    Frenzel T; Hoffmann B; Schmitz R; Bethge A; Schumacher U; Wedemann G
    PLoS One; 2017; 12(11):e0187144. PubMed ID: 29107953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glycans in the development and progression of prostate cancer.
    Munkley J; Mills IG; Elliott DJ
    Nat Rev Urol; 2016 Jun; 13(6):324-33. PubMed ID: 27091662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.
    Wang J; Zou JX; Xue X; Cai D; Zhang Y; Duan Z; Xiang Q; Yang JC; Louie MC; Borowsky AD; Gao AC; Evans CP; Lam KS; Xu J; Kung HJ; Evans RM; Xu Y; Chen HW
    Nat Med; 2016 May; 22(5):488-96. PubMed ID: 27019329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.
    Yang L; Dutta SM; Troyer DA; Lin JB; Lance RA; Nyalwidhe JO; Drake RR; Semmes OJ
    Oncotarget; 2015 Dec; 6(41):43743-58. PubMed ID: 26497208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer.
    Lange T; Kupfernagel M; Wicklein D; Gebauer F; Maar H; Brügge K; Müller I; Simon R; Schlomm T; Sauter G; Schumacher U
    Clin Cancer Res; 2014 Apr; 20(7):1791-802. PubMed ID: 24526735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
    Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
    Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
    Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
    Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.